Spurt Medical Technologies Limited
About Spurt Medical Technologies Limited
Data last updated:
Spurt Medical Technologies Limited is a public limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 July 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1994PLC060337.
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹23.01 Lakh. It is led by directors including Rajpal Singh and Harnath Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 10 3rd Floor Satya Niketan, New Delhi, Delhi, India – 110021.
As per the financials filed for FY 2023, the company reported a revenue of ₹35,700, a decline of 75% compared to the previous year. For the same year it recorded a net loss of ₹20,950 (net margin -58.7%) and EBITDA of ₹8,550 (EBITDA margin 23.9%). Revenue has declined at a compounded annual rate (CAGR) of 45% over three years and 71% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Spurt Medical Technologies has one previous CIN (Corporate Identification Number): L74899DL1994PLC060337. The current CIN is U74899DL1994PLC060337, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74899DL1994PLC060337 | Current |
| L74899DL1994PLC060337 | Previous |
Contact details
Spurt Medical Technologies Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address10 3rd Floor Satya Niketan, New Delhi, Delhi, India – 110021
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Spurt Medical Technologies Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Spurt Medical Technologies Limited
FY 2025 filings availableSpurt Medical Technologies Limited reported revenue of ₹35,700 (down 75% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 71% over five years, including a 75% fall in the latest year. EBITDA fell 64% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹35,700 | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8,550 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹20,950 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 23.9% | ||||
| Net Profit Margin | -58.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Spurt Medical Technologies Limited, buy the company report.
Board of directors of Spurt Medical Technologies Limited
Spurt Medical Technologies has 5 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajpal Singh Also directs: R3r Impex Private Limited, Ambey Transport Private Limited | Director | 11 Oct 2021 | 5 Years 0 Months | Current |
| Harnath Singh Also directs: Westend Estates Pvt.Ltd. | Director | 20 Nov 2018 | 7 Years 11 Months | Current |
| Ranjeet Singh Gour | Director | 11 Oct 2021 | 5 Years 0 Months | Current |
| Mahi Pal Arha | Director | 12 Apr 2019 | 7 Years 6 Months | Current |
| Pawan Mathuria | Director | 13 Jul 2017 | 9 Years 3 Months | Current |
Auditor
Spurt Medical Technologies Limited is audited by GOPI AGGARWAL & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GOPI AGGARWAL & CO. | FY 2023 | 094708 |
Shareholding
The shareholding of Spurt Medical Technologies Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Spurt Medical Technologies Limited, buy the company report.
Legal cases
No court or tribunal cases involving Spurt Medical Technologies Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Spurt Medical Technologies Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Spurt Medical Technologies has 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
GST
No GST registration is on our record for Spurt Medical Technologies Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Spurt Medical Technologies Limited has 12 board changes on record since 2016: 5 appointments and 7 cessations. The latest: Vijendra Singh ceased to be Director on 02 Jun 2022.
3 earlier events are in the company report.
Frequently asked questions
Spurt Medical Technologies is an active public limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 July 1994 (32+ years old) and is registered under CIN U74899DL1994PLC060337.
Spurt Medical Technologies has 5 current directors:
- Rajpal Singh - Director
- Harnath Singh - Director
- Ranjeet Singh Gour - Director
- Mahi Pal Arha - Director
- Pawan Mathuria - Director
The latest financial statements of Spurt Medical Technologies on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Spurt Medical Technologies is U74899DL1994PLC060337. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Spurt Medical Technologies was incorporated on 20 July 1994, making it 32+ years old. It is registered with the Registrar of Companies, Delhi.
Vijendra Singh ceased to be Director on 02 Jun 2022. Rajpal Singh was appointed as Director on 11 Oct 2021. Ranjeet Singh Gour was appointed as Director on 11 Oct 2021. Spurt Medical Technologies has 12 board changes on record in total.
The registered office of Spurt Medical Technologies is at 10 3rd Floor Satya Niketan, New Delhi, Delhi, India – 110021.
Spurt Medical Technologies operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Spurt Medical Technologies is compliant as of 17 July 2026. The company is actively filing with the Registrar of Companies.
Spurt Medical Technologies can be reached at its registered office: 10 3rd Floor Satya Niketan, New Delhi, Delhi, India – 110021.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
